Inicio > Oftalmología > Tratamiento médico de las cataratas (su casi carencia) > Página 2

Tratamiento médico de las cataratas (su casi carencia)

Referencias bibliográficas

1. Jacobs DS Cataract in adults, en: UptoDate ® Topic 6904 Version 17.0
2. Universidad de Salamanca. Diccionario médico-biológico, histórico y etimológico (dicciomed.eusal.es)
3. Thylefors B, Négrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995;73:115

4. Thylefors B. The World Health Organization’s programme for the prevention of blindness. Int Ophthalmol 1990;14:211
5. Mathew MC, Ervin AM, Tao J, Davis RM. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane Database Syst Rev 2012;6:CD004567
6. Vitamins for cataract prevention. Med Lett Drugs Ther 2008;50:46

7. Rautiainen S, Ejdervik LB, Morgenstern R, Wolk A. Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women. Am J Clin Nutr doi: 10.3945/ajcn.2009.28528
8. Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women. A prospective study. Arch Ophthalmol 2008;126(1):102-109
9. Adamek B, Samochowiec L, Wojcicki J. The treatment of senile cataract using Mucokehl ® eye drops. Results of a trial carried out in an eye hospital. Semmelweis-Institut GmbH. Verlag für Naturheilkunde 27318 Hoya Germany
10. Polunin GS, Makarova IA, Bubnova IA. Efficacy of catalin eyed drops in age-related cataract agents. Vestn Oftalmol 2010 jan.-feb.;126(1):36-39
11. Kociecki J, Załecki K, Wasiewicz-Rager J, Pecold K. Evaluation of effectiveness of Catalin eyedrops in patients with presenile and senile cataract. Klin Oczna 2004;106(6):778-782
12. Angra SK, Mohan M, Saini JS. Medical therapy of cataract (evaluation of Catalin). Indian J Ophthalmol 1983 jan.;31(1):5-8
13. Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Doroshenko VS y cols. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs R D. 2002;3(2):87-103
14. Skromne-Kadlubik G, Hidalgo-Rico R. Prevención de la formación de cataratas con anticuerpos monoclonales anti factor de necrosis tumoral. Rev Hosp Jua Mex 2005;72(2):63-64
15. Rakel D. Integrative Medicine. W. B. Saunders Co., St. Louis, MO, 2012:762-763
16. Nishimoto S, Kawane K, Watanabe-Fukunaga R, Fukuyama H, Ohsawa Y, Uchiyama Y, y cols. Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature 2003 aug. 28;424:1071-1074